Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Redefining multiple sclerosis therapy through microbial immunomodulation and epigenetic control

Journal of Translational Autoimmunity(2025)10.1016/j.jtauto.2025.100313Source: DataRank Database

Redefining multiple sclerosis therapy through microbial immunomodulation and epigenetic control is a research paper published in Journal of Translational Autoimmunity (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.00)OA: goldTopics (16)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Christina J. Thomas,Sunilgowda Sunnagatta Nagaraja ORCID,Rakesh Kumar ORCID,K. Sawant ORCID,Duminduni H. Angappulige ORCID

Live enrichment

PubMed:40978496 PMC:PMC12446548 OpenAlex:https://openalex.org/W4413844510

National Institutes of Health

Grant: 1R21AI167793

National Institutes of Health

Grant: R01CA273002

National Institutes of Health

Grant: R01CA282254

National Institutes of Health

Grant: 1R21AI167793-01A1

Combating chronic neuroinflammatory disorders by targeting NAC1

National Institutes of Health

Grant: 1R01CA282254-01A1

Integrative Targeted Therapy for Melanoma

National Institutes of Health

Grant: 5R01CA273002-02

Combating melanoma with an attenuated bacterial therapeutic

Foundation for the National Institutes of Health

FWCI

0.00

Citation Percentile

0.1%

goldLicense: cc-by

journalhttps://doi.org/10.1016/j.jtauto.2025.100313

publisherhttps://doi.org/10.1016/j.jtauto.2025.100313

publisherhttps://api.elsevier.com/content/article/PII:S2589909025000486?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2589909025000486?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40978496

Fields of Study

Tryptophan and brain disordersImmune responses and vaccinationsCancer Research and Treatments0301 basic medicine03 medical and health sciences

Keywords

Multiple sclerosisEpigeneticsMedicineNeuroscienceBiologyImmunologyGeneticsneuroinflammationMicrobiomeT Cell RegulationReview article

Sustainable Development Goals

SDG 0: Zero hunger